Antioxidants & redox signaling

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas. ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes. ARS coverage includes: -ROS/RNS as messengers -Gaseous signal transducers -Hypoxia and tissue oxygenation -microRNA -Prokaryotic systems -Lessons from plant biology

Antioxidants & redox signaling（ARS）是一本同行评审的领先期刊，专注于探索氧气及氧化还原过程在人类健康和疾病中扮演的关键角色。该杂志深入研究了氧化还原疗法在遗传学、制药学和营养学等领域的重要问题，并关注结构生物学、干细胞研究、再生医学、表观遗传学、成像技术、临床成果以及预防和治疗营养等前沿科学领域的最新进展。 ARS期刊通过创建两个独特的焦点——《ARS发现》和《ARS治疗》——进一步扩展了其影响力。《ARS发现》（每年24期）发表基础研究和应用研究中最高水平的突破性成果，而《ARS治疗》（每年12期）则是该领域中首本专注于展示氧化还原科学如何改变健康结果的期刊，旨在推动整个氧化还原生物学领域的发展。 此外，ARS的报道内容还包括ROS/RNS作为信号分子的角色、气体信号转换器、缺氧与组织氧合的机制、微小核糖核酸（miRNA）的调控作用、原核系统中的氧化还原过程，以及植物生物学中可为人类健康提供启示的研究。这些内容丰富了我们对氧化还原信号在生物体内作用机制的理解，并为开发新的治疗策略提供了科学基础。